In addition to the role of BCL-xL in tumor suppression, the expression of this protein has been related to other malignant processes such as invasive capacity [15], induction of transitional mesenchymal epithelium, and metastasis independent of its antiapoptotic activity [16]. Here, BCL2L1 is linked to neoplasm.